The DOI matches its Crossref record; 283 of the 283 references it cites were found in a registry or an index.
DNA Damage Response Genes and the Development of Cancer Metastasis
Open accessAbstract
DNA damage response genes play vital roles in the maintenance of a healthy genome. Defects in cell cycle checkpoint and DNA repair genes, especially mutation or aberrant downregulation, are associated with a wide spectrum of human disease, including a predisposition to the development of neurodegenerative conditions and cancer. On the other hand, upregulation of DNA damage response and repair genes can also cause cancer, as well as increase resistance of cancer cells to DNA damaging therapy. In recent years, it has become evident that many of the genes involved in DNA damage repair have additional roles in tumorigenesis, most prominently by acting as transcriptional (co-)factors. Although defects in these genes are causally connected to tumor initiation, their role in tumor progression is more controversial and it seems to depend on tumor type. In some tumors like melanoma, cell cycle checkpoint/DNA repair gene upregulation is associated with tumor metastasis, whereas in a number of other cancers the opposite has been observed. Several genes that participate in the DNA damage response, such as RAD9, PARP1, BRCA1, ATM and TP53 have been associated with metastasis by a number of in vitro biochemical and cellular assays, by examining human tumor specimens by immunohistochemistry or by DNA genome-wide gene expression profiling. Many of these genes act as transcriptional effectors to regulate other genes implicated in the pathogenesis of cancer. Furthermore, they are aberrantly expressed in numerous human tumors and are causally related to tumorigenesis. However, whether the DNA damage repair function of these genes is required to promote metastasis or another activity is responsible (e.g., transcription control) has not been determined. Importantly, despite some compelling in vitro evidence, investigations are still needed to demonstrate the role of cell cycle checkpoint and DNA repair genes in regulating metastatic phenotypes in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–283 of 283
The human Rad9–Rad1–Hus1 checkpoint complex stimulates flap endonuclease 1
Wang, W., Brandt, P., Rossi, M. L., Lindsey-Boltz, L., Podust, V., Fanning, E., Sancar, A., & Bambara, R. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407686101 · Cited by 98
c-Abl Tyrosine Kinase Regulates the Human Rad9 Checkpoint Protein in Response to DNA Damage
Yoshida, K., Komatsu, K., Wang, H., & Kufe, D. W. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.10.3292-3300.2002 · Cited by 98
Redox-Based Escape Mechanism from Death: The Cancer Lesson
Pani, G., Giannoni, E., Galeotti, T., & Chiarugi, P. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2739 · Cited by 96
Ogino, S., Hazra, A., Tranah, G. J., Kirkner, G. J., Kawasaki, T., Nosho, K., Ohnishi, M., Suemoto, Y., Meyerhardt, J. A., Hunter, D. J., et al. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm160 · Cited by 96
Brca2, Rad51 and Mre11: Performing balancing acts on replication forks
Costanzo, V. (2011) · DNA repair · doi:10.1016/j.dnarep.2011.07.009 · Cited by 94
Komuro, Y., Watanabe, T., Hosoi, Y., Matsumoto, Y., Nakagawa, K., Tsuno, N. H., Kazama, S., Kitayama, J., Suzuki, N., & Nagawa, H. (2002) · Cancer · doi:10.1002/cncr.10807 · Cited by 94
Balajee, A. S., & Geard, C. R. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.07.022 · Cited by 93
CHK1 frameshift mutations in genetically unstable colorectal and endometrial cancers
Bertoni, F., Codegoni, A. M., Furlan, D., Tibiletti, M. G., Capella, C., & Broggini, M. (1999) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199910)26:2<176::aid-gcc11>3.3.co;2-v · Cited by 92
Chiang, Y.-C., Teng, S., Su, Y., Hsieh, F., & Wu, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212043200 · Cited by 91
Zeng, Z.-Z., Jia, Y., Hahn, N. J., Markwart, S. M., Rockwood, K. F., & Livant, D. L. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4400 · Cited by 89
DNA Damage Repair and Response Proteins as Targets for Cancer Therapy
Lieberman, H. B. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708783497328 · Cited by 89
Self-citationCHK2 kinase expression is down-regulated due to promoter methylation in non-small cell lung cancer.
Zhang, P., Wang, J., Gao, W., Yuan, B., Rogers, J., & Reed, E. (2004) · Molecular Cancer · doi:10.1186/1476-4598-3-14 · Cited by 88
Fen-1 Facilitates Homologous Recombination by Removing Divergent Sequences at DNA Break Ends
Kikuchi, K., Taniguchi, Y., Hatanaka, A., Sonoda, E., Hochegger, H., Adachi, N., Matsuzaki, Y., Koyama, H., van Gent, D. C., Jasin, M., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.16.6948-6955.2005 · Cited by 88
BRCA1: exploring the links to transcription
Monteiro, Á. N. A. (2000) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)01632-7 · Cited by 87
Wang, W. T., Hüper, G., Guo, Y., Murphy, S. K., Olson, J. A., & Marks, J. R. (2005) · Oncogene · doi:10.1038/sj.onc.1208464 · Cited by 87
Roddam, P. L., Rollinson, S. J., O’Driscoll, M., Jeggo, P. A., Jack, A., & Morgan, G. J. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.12.900 · Cited by 84
Targeting EGFR Induced Oxidative Stress by PARP1 Inhibition in Glioblastoma Therapy
Nitta, M., Kozono, D., Kennedy, R. D., Stommel, J. M., Ng, K., Zinn, P. O., Kushwaha, D. S., Kesari, S., Furnari, F. B., Hoadley, K. A., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010767 · Cited by 82
Role of ERCC1 promoter hypermethylation in drug resistance to cisplatin in human gliomas
Chen, H., Shao, C., Chen, F., Kwan, A., & Chen, Z. (2009) · International Journal of Cancer · doi:10.1002/ijc.24772 · Cited by 81
Integrin‐linked kinase regulates E‐cadherin expression through PARP‐1
McPhee, T. R., McDonald, P. C., Oloumi, A., & Dedhar, S. (2008) · Developmental Dynamics · doi:10.1002/dvdy.21685 · Cited by 80
Marino, N., Nakayama, J., Collins, J. W., et al. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9374-8 · Cited by 80
Yamasawa, K., Nio, Y., Dong, M., Yamaguchi, K., & Itakura, M. (2002) · PubMed · Cited by 78
Demuth, I., & Digweed, M. (2007) · Oncogene · doi:10.1038/sj.onc.1210876 · Cited by 77
Chen, Y., Su, Y.-N., Chou, P. C., Chiang, W., Chang, M.-C., Wang, L. S., Teng, S., & Wu, K.-J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501449200 · Cited by 75
Poly(ADP-ribose)-dependent regulation of Snail1 protein stability
Rodríguez, M. I., González-Flores, A., Dantzer, F., Collard, J. G., de Herreros, A. G., & Oliver, F. J. (2011) · Oncogene · doi:10.1038/onc.2011.153 · Cited by 72
Bao, S., Lu, T., Wang, X. A., Zheng, H., Wang, L., Wei, Q., Hittelman, W. N., & Li, L. (2004) · Oncogene · doi:10.1038/sj.onc.1207753 · Cited by 72
Poly(ADP-ribose) polymerase-1 mRNA expression in human breast cancer: a meta-analysis
Gonçalvès, A., Finetti, P., Sabatier, R., Gilabert, M., Adélaïde, J., Borg, J., Chaffanet, M., Viens, P., Birnbaum, D., & Bertucci, F. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1199-y · Cited by 70
Singh, K., Mogare, D., Giridharagopalan, R. O., Gogiraju, R., Pande, G., & Chattopadhyay, S. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000660 · Cited by 69
Metastasis suppressor function of NM23‐H1 requires its 3′‐5′ exonuclease activity
Zhang, Q., McCorkle, J. R., Novak, M., Yang, M., & Kaetzel, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25307 · Cited by 67
Zhang, Y., Lim, C. U. K., Williams, E. S., Zhou, J., Zhang, Q., Fox, M. H., Bailey, S. M., & Liber, H. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4368 · Cited by 67
Epigenetic Drivers of Genetic Alterations
Toyota, M., & Suzuki, H. (2010) · Advances in genetics · doi:10.1016/b978-0-12-380866-0.60011-3 · Cited by 66
Hiraoka, L. R., Harrington, J., Gerhard, D. S., Lieber, M. R., & Hsieh, C. (1995) · Genomics · doi:10.1016/0888-7543(95)80129-a · Cited by 66
Cloning of novel mammary tumor progression and metastasis genes
Kimm, M. A., Boer, M., Gaemers, I. C., & Hilkens, J. (2001) · Breast Cancer Research · doi:10.1186/bcr362 · Cited by 65
Role of Tip60 in Human Melanoma Cell Migration, Metastasis, and Patient Survival
Chen, G., Cheng, Y., Tang, Y., Martinka, M., & Li, G. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.193 · Cited by 65
Wang, L., Hsu, C., Ni, J., Wang, P., Yeh, S., Keng, P., & Chang, C. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.5.2202-2213.2004 · Cited by 65
A novel role for BRCA1 in regulating breast cancer cell spreading and motility
Coene, E. D., Gadelha, C., White, N., Malhas, A. N., Thomas, B., Shaw, M. K., & Vaux, D. J. (2011) · The Journal of Cell Biology · doi:10.1083/jcb.201004136 · Cited by 65
Heterozygous ATR Mutations in Mismatch Repair–Deficient Cancer Cells Have Functional Significance
Lewis, K. A., Mullany, S. A., Thomas, B., CHIEN, J. R., Loewen, R. T., Shridhar, V., & Cliby, W. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1019 · Cited by 63
Budzowska, M., Jaspers-Dekker, I., Essers, J., de Waard, H., van Drunen, E., Hanada, K., Beverloo, B., Hendriks, R. W., de Klein, A., Kanaar, R., et al. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600353 · Cited by 62
Singh, P., Zheng, L., Chavez, V., Qiu, J., & Shen, B. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606582200 · Cited by 62
Wu, J., Wang, J., Lai, J.-C., Cheng, Y., Yeh, K.-T., Wu, T., Chen, C., & Lee, H. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-008-0078-9 · Cited by 61
Human RAD9 checkpoint control/proapoptotic protein can activate transcription of p21
Yin, Y., Zhu, A., Jin, Y. J., Liu, Y., Zhang, X., Hopkins, K. M., & Lieberman, H. B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403130101 · Cited by 56
Self-citationModulation of Cellular Response to Cisplatin by a Novel Inhibitor of DNA Polymerase β
Boudsocq, F., Benaim, P., Canitrot, Y., Knibiehler, M., Ausseil, F., Capp, J., Bieth, A., Long, C., David, B., Shevelev, I., et al. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.001776 · Cited by 56
Fhit and CHK1 Have Opposing Effects on Homologous Recombination Repair
Hu, B., Wang, H., Wang, X., Lu, H., Huang, C.-F., Powell, S. N., Huebner, K., & Wang, Y. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1966 · Cited by 54
Jarrett, S. G., Novak, M., Dabernat, S., Daniel, J. Y., Mellon, I., Zhang, Q., Harris, N., Ciesielski, M. J., Fenstermaker, R. A., Kovacic, D., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1795 · Cited by 54
Fischler, T., Li, Y., Wang, R.-H., Kim, H.-S., Sengupta, K., Vassilopoulos, A., Lahusen, T. J., Xu, X., Lee, M.-H., Liu, Q., et al. (2010) · Oncogene · doi:10.1038/onc.2010.163 · Cited by 51
Down-regulation of Tip60 gene as a potential marker for the malignancy of colorectal cancer.
Sakuraba, K., Yasuda, T., 坂田, 真., Kitamura, Y.-H., Shirahata, A., Goto, T., Mizukami, H., Saito, M., Ishibashi, K., Kigawa, G., et al. (2009) · PubMed · Cited by 50
Rigas, B., Borgo, S., Elhosseiny, A. A., Balatsos, V. E., Manika, Z., Shinya, H., Kurihara, N., Go, M., & Lipkin, M. (2001) · PubMed · Cited by 49
Rad9 Has a Functional Role in Human Prostate Carcinogenesis
Zhu, A., Zhang, C. X., & Lieberman, H. B. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2304 · Cited by 49
Self-citationRad9 plays an important role in DNA mismatch repair through physical interaction with MLH1
He, W., Zhao, Y., Zhang, C., An, L., Hu, Z., Liu, Y., Han, L., Bi, L., Xie, Z., Xue, P., et al. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn686 · Cited by 48
Inhibition of cancer cell growth by BRCA2.
Wang, S., Shao, R., Pao, A., Zhang, S., Hung, M., & Su, L. (2002) · PubMed · Cited by 47
Profiling of the BRCA1 transcriptome through microarray and ChIP-chip analysis
Gorski, J. J., Savage, K. I., Mulligan, J. M., McDade, S. S., Blayney, J. K., Ge, Z., & Harkin, D. P. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr679 · Cited by 46
Moro, L., Arbini, A., Yao, J. L., di Sant'Agnese, P. A., Marra, E., & Greco, M. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2007.00719.x · Cited by 45
Telomeric fusions in cultured human fibroblasts as a source of genomic instability
Riboni, R., Casati, A., Nardo, T., Zaccaro, E., Ferretti, L., Nuzzo, F., & Mondello, C. (1997) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(96)00248-8 · Cited by 45
MGMT promoter hypermethylation in a series of 104 glioblastomas.
Mellai, M., Caldera, V., Annovazzi, L., Chiò, A., Lanotte, M., Cassoni, P., Finocchiaro, G., & Schiffer, D. (2009) · PubMed · Cited by 45
Cdc25B is negatively regulated by p53 through Sp1 and NF-Y transcription factors
Dalvai, M., Mondésert, O., Bourdon, J., Ducommun, B., & Dozier, C. (2011) · Oncogene · doi:10.1038/onc.2010.588 · Cited by 44
Yang, J., Xu, Z., Li, J., Zhang, R., Zhang, G., Ji, H., Song, B., & Chen, Z. (2010) · The Journal of Urology · doi:10.1016/j.juro.2010.03.044 · Cited by 42
DNA repair: the culprit for tumor-initiating cell survival?
Mathews, L., Cabarcas‐Petroski, S., & Farrar, W. L. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9277-0 · Cited by 42
Kim, N., Choi, Y. R., Baek, M. J., Kim, Y. H., Kang, H., Kim, N. K., Min, J. S., & Kim, H. (2001) · YUHSpace (Yonsei University Medical Library) · Cited by 41
Mouse Rad1 deletion enhances susceptibility for skin tumor development
Han, L., Hu, Z., Liu, Y., Wang, X., Hopkins, K. M., Lieberman, H. B., & Hang, H. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-67 · Cited by 39
Self-citationBroustas, C. G., Zhu, A., & Lieberman, H. B. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.402784 · Cited by 38
Self-citationAberrant Polo-Like Kinase 1-Cdc25A Pathway in Metastatic Hepatocellular Carcinoma
Wang, X. Q., Zhu, Y., Lui, K. S., Cai, Q., Lü, P., & Poon, R. T. P. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0626 · Cited by 38
BRIT1/MCPH1: A Guardian of Genome and an Enemy of Tumors
Chaplet, M., Rai, R., Jackson-Bernitsas, D., Li, K., & Lin, S. (2006) · Cell Cycle · doi:10.4161/cc.5.22.3471 · Cited by 37
Detection of genetic alterations in hereditary colorectal cancer screening
Pineda, M., González, S., Lázaro, C., Blanco, I., & Capellá, G. (2009) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2009.11.002 · Cited by 37
Ishii, H., Inageta, T., Mimori, K., Saito, T., Sasaki, H., Isobe, M., Mori, M., Croce, C. M., Huebner, K., Ozawa, K., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504222102 · Cited by 37
Contributions of Rad9 to tumorigenesis
Broustas, C. G., & Lieberman, H. B. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23424 · Cited by 33
Self-citationSmilenov, L. B., Lieberman, H. B., Mitchell, S. A., Baker, R. A., Hopkins, K. M., & Hall, E. J. (2005) · Cancer Research · doi:10.1158/0008-5472.933.65.3 · Cited by 32
Self-citationWang, X., Hu, B., Weiss, R. S., & Wang, Y. (2005) · Oncogene · doi:10.1038/sj.onc.1209212 · Cited by 31
Association BetweenMGMTPromoter Hypermethylation and p53 Mutation in Glioblastoma
Shamsara, J., Sharif, S., Afsharnezhad, S., Lotfi, M., Raziee, H., Ghaffarzadegan, K., Moradi, A., Rahighi, S., & Behravan, J. (2009) · Cancer Investigation · doi:10.1080/07357900902783211 · Cited by 29
Gadd45a regulates β-catenin distribution and maintains cell–cell adhesion/contact
Ji, J., Liu, R., Tong, T., Song, Y., Jin, S., Wu, M., & Zhan, Q. (2007) · Oncogene · doi:10.1038/sj.onc.1210469 · Cited by 27
The role of BRCA1 and BRCA2 in prostate cancer
Jensen, R. A. (2013) · Frontiers in bioscience · doi:10.2741/4191 · Cited by 27
Gadd45a inhibits cell migration and invasion by altering the global RNA expression
Shan, Z., Li, G., Zhan, Q., & Li, D. (2012) · Cancer Biology & Therapy · doi:10.4161/cbt.21186 · Cited by 26
Wei, Q., Cheng, L., Xie, K., Bucana, C. D., & Dong, Z. (1997) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12285608 · Cited by 24
Marignac, V. L. M., Rodrigue, A., Davidson, D. L., Couillard, M., Al-Moustafa, A.-E., Abramovitz, M., Foulkes, W. D., Masson, J., & Aloyz, R. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016394 · Cited by 23
Differential Impact of MouseRad9Deletion on Ionizing Radiation-Induced Bystander Effects
Zhu, A., Zhou, H., Leloup, C., Marino, S. A., Geard, C. R., Hei, T. K., & Lieberman, H. B. (2005) · Radiation Research · doi:10.1667/rr3458.1 · Cited by 23
Self-citationWang, X.-F., Wang, L., Callister, M. D., Putnam, J. B., Mao, L., & Li, L. (2001) · PubMed · Cited by 22
Kinzel, B., Hall, J., Natt, F., Weiler, J., & Cohen, D. (2002) · Cancer · doi:10.1002/cncr.10383 · Cited by 21
Zhou, Z., Jing, C., Zhang, L., Fujita, T., Kim, H., Huang, Y., Liu, Z., & Wan, Y. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.456962 · Cited by 21
Wang, J. Y., Ho, T., Trojanek, J., Chintapalli, J., Grabacka, M., Stokłosa, T., Garcia, F. U., Skórski, T., & Reiss, K. (2005) · Oncogene · doi:10.1038/sj.onc.1208537 · Cited by 19
Balmus, G., Zhu, M., Mukherjee, S., Lyndaker, A. M., Hume, K. R., Lee, J., Riccio, M. L., Reeves, A. P., Sutter, N. B., Noden, D. M., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds173 · Cited by 18
Checkpoint protein Rad9 plays an important role in nucleotide excision repair
Li, T., Wang, Z., Zhao, Y., He, W., An, L., Liu, S., Liu, Y., Wang, H., & Hang, H. (2013) · DNA repair · doi:10.1016/j.dnarep.2013.01.006 · Cited by 17
Bringing H2AX into the Angiogenesis Family
Rankin, E. B., Giaccia, A. J., & Hammond, E. M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.05.004 · Cited by 16
Loss of Hus1 sensitizes cells to etoposide-induced apoptosis by regulating BH3-only proteins
Meyerkord, C. L., Takahashi, Y., Araya, R., Takada, N., Weiss, R. S., & Wang, H.-G. (2008) · Oncogene · doi:10.1038/onc.2008.336 · Cited by 16
The Rad9 protein enhances survival and promotes DNA repair following exposure to ionizing radiation
Brandt, P. D., Helt, C. E., Keng, P. C., & Bambara, R. A. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.06.064 · Cited by 16
Downregulation of RAD17 in head and neck cancer
Zhao, M., Begum, S., Ha, P. K., Westra, W. H., & Califano, J. A. (2007) · Head & Neck · doi:10.1002/hed.20660 · Cited by 12
Cited by
DNA Damage/Repair Management in Cancers
Alhmoud, J. F., Woolley, J. F., Al Moustafa, A.-E., & Malki, M. I. (2020) · Cancers · doi:10.3390/cancers12041050 · Cited by 362
Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistance
Narayanan, S., Cai, C.-Y., Assaraf, Y. G., Guo, H.-Q., Cui, Q., Wei, L., Huang, J.-J., Ashby, C. R., & Chen, Z.-S. (2020) · Drug Resistance Updates · doi:10.1016/j.drup.2019.100663 · Cited by 332
The safety of nanomaterials in food production and packaging
Onyeaka, H., Passaretti, P., Miri, T., & Al-Sharify, Z. T. (2022) · Current Research in Food Science · doi:10.1016/j.crfs.2022.04.005 · Cited by 319
Barnes, J. L., Zubair, M., John, K., Poirier, M. C., & Martin, F. L. (2018) · Biochemical Society Transactions · doi:10.1042/bst20180519 · Cited by 318
Extensive loss of cell-cycle and DNA repair genes in an ancient lineage of bipolar budding yeasts
Steenwyk, J. L., Opulente, D. A., Kominek, J., Shen, X.-X., Zhou, X., Labella, A. L., Bradley, N. P., Eichman, B. F., Čadež, N., Libkind, D., et al. (2019) · PLoS Biology · doi:10.1371/journal.pbio.3000255 · Cited by 162
Metadata
- Authors
- Broustas, C. G., & Lieberman, H. B.
- Venue
- Radiation Research
- Publisher
- Radiation Research Society
- Published
- 2014-02
- Volume
- 181
- Issue
- 2
- Pages
- 111-130
- ISSN
- 0033-7587 (ISSN-L)
- 1938-5404
- OpenAlex
- W2120211376
- Cited by
- 275
- References
- 283
- FWCI
- 5.11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.